CES & MET Webinar for Healthcare Practitioners

Webinar Includes:

Research Studies

Alpha-Stim® has been on the market as a pain and mental health solution for over 37 years and has more research than any other therapeutic MET or CES device. There are over 100 studies published to date and over 20 currently underway. Our research is so good even our competitors use it! FDA accepts a broad range of waveform parameters for the CES category, which is not unusual. For example, both aspirin and morphine are categorized as analgesics but we all understand the considerable differences between the two. Only Alpha-Stim is proven to get the results shown in Alpha-Stim research.

Instructions for Use

Alpha-Stim’s patented waveform is delivered using our unique, patented Earclip Electrodes, Smart Probes or AS-Trodes™. The ears are an efficient and easy way to apply electrodes to direct the current across the brain stem. LORETA (computerized EEG) studies prove that Alpha-Stim® CES device technology affects the whole brain from the earclip application.

Handheld probes or attachable self-adhesive electrodes are used for site-specific microcurrent electrical therapy. The webinar will include detailed protocols developed specifically for Alpha-Stim and proven to provide acute, post-traumatic and chronic pain relief and pain management.

Contraindications & Adverse Effects

We’ll cover risk information and adverse effects from data on approximately 8,800 patients participating in 144 controlled studies and open clinical trials.

Webinar Signup Form

If you are a licensed healthcare practitioner and would like to attend a CES and MET education webinar with Steve Haltiwanger, MD, Chief Medical Officer, please fill out the form below and we will contact you with upcoming live webinar dates.If you would prefer to watch a pre-recorded webinar, please check the appropriate box below and we will email a personal invitation via webex.
  • This field is for validation purposes and should be left unchanged.

Webinar Presenter

Steve Haltiwanger, MD, CCN, FAIS
Chief Medical Officer

Dr. Steve Haltiwanger is currently the Chief Medical Officer at EPI. In the past, he has been the Medical Director of two other companies.

After earning a B.S. in Professional Chemistry from Valdosta State University in Valdosta, Georgia, Dr. Haltiwanger attended the Medical College of Georgia. While there he completed medical school and a one-year fellowship in Pathology. He graduated from the Medical College of Georgia with an M.D. degree in 1980. He completed a Psychiatry and Neurology residency at the University of South Carolina in 1984. In 2003, he became a CCN (Certified Clinical Nutritionist). He currently is a member of the scientific council of the International and American Association of Clinical Nutritionists.

Over the last 20 years, Dr. Haltiwanger has been involved in 72 research studies. Dr. Haltiwanger’s past research includes electromagnetic, acoustic and phototherapy treatments. He has also researched the effects of PEMF on neurological diseases (multiple sclerosis and diabetic neuropathy).

In the last 34 years has lectured in 17 countries and at dozens of scientific conferences.